Christine OReilly - CSL Independent Non-Executive Director
CSLLY Stock | USD 90.71 1.54 1.73% |
Director
Ms. Christine Elizabeth OReilly is Independent NonExecutive Director of CSL Limited. She was appointed to the CSL Board in February 2011. She is a Director of Transurban, Energy Australia, Medibank Private Limited and Baker Heart Diabetes Institute. Ms OReilly has in excess of 30 years financial and operational business experience in domestic and offshore organisations. During her executive career, she was CoHead of Unlisted Infrastructure Investments at Colonial First State Global Asset Management and prior to that was the Chief Executive Officer of the GasNet Australia Group. since 2011.
Age | 56 |
Tenure | 13 years |
Phone | 61 3 9389 1911 |
Web | https://www.csl.com.au |
CSL Management Efficiency
The company has return on total asset (ROA) of 0.0613 % which means that it generated a profit of $0.0613 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1338 %, meaning that it generated $0.1338 on every $100 dollars invested by stockholders. CSL's management efficiency ratios could be used to measure how well CSL manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | DIRECTOR Age | ||
John Suk | Covalon Technologies | N/A | |
Elinor Caplan | Covalon Technologies | N/A | |
William Li | Ceapro Inc | 49 | |
Donald Oborowsky | Ceapro Inc | N/A | |
Martin Bernholtz | Covalon Technologies | N/A | |
Ian Brindle | Covalon Technologies | N/A | |
John Hands | Covalon Technologies | N/A | |
Murray Miller | Covalon Technologies | N/A | |
Jeffrey Mandel | Covalon Technologies | N/A | |
Myrna Francis | Covalon Technologies | N/A | |
Joseph Cordiano | Covalon Technologies | N/A | |
Gale Pollock | Covalon Technologies | N/A | |
John Zupancic | Ceapro Inc | N/A | |
Ulrich Kosciessa | Ceapro Inc | N/A | |
Ronald Smith | Covalon Technologies | 66 | |
Glenn Rourke | Ceapro Inc | N/A |
Management Performance
Return On Equity | 0.13 | |||
Return On Asset | 0.0613 |
CSL Leadership Team
Elected by the shareholders, the CSL's board of directors comprises two types of representatives: CSL inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CSL. The board's role is to monitor CSL's management team and ensure that shareholders' interests are well served. CSL's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CSL's outside directors are responsible for providing unbiased perspectives on the board's policies.
Paul McKenzie, Chief Officer | ||
Alan Wills, Senior Vice President of Strategy and Business Development | ||
BS BS, Exec Counsel | ||
Val Romberg, Executive Vice President of Manufacturing and Planning | ||
Edward Bailey, Company Secretary | ||
Brian McNamee, Non-Executive Independent Director | ||
Bill Campbell, Executive Vice President Chief Commercial Officer | ||
Wilfried Freudenberg, Department Production | ||
Bob Repella, Executive Vice President - Global Commercial Operations | ||
Abbas Hussain, Director | ||
Bernard Ronchi, Senior Manager, Investor Relations | ||
Laurie Cowan, Sr. VP of HR | ||
MS BA, Ex Officer | ||
Greg Boss, Group General Counsel, Executive Vice President - Legal | ||
John Akehurst, Independent Non-Executive Director | ||
Karen Etchberger, Executive VP of Quality and Bus. Services | ||
Jemimah Brennan, Head Pacific | ||
Mark Dehring, Head of Investor Relations | ||
Fiona Mead, Company Secretary and Head of Group Governance | ||
Andrew Cuthbertson, Chief Scientific Officer, R&D Director | ||
Megan Clark, Director | ||
Paul Perreault, CEO, Managing Director, Executive Director | ||
Robert Cuthbertson, Chief Scientific Officer, R&D Director, Director | ||
David Anstice, Independent Non-Executive Director | ||
Shah Hussain, Director | ||
Paul BA, CEO MD | ||
Bruce Brook, Independent Non-Executive Director | ||
Christine OReilly, Independent Non-Executive Director | ||
Mary Sontrop, Executive Vice President - Manufacturing and Planning | ||
BCom BComm, Chief Officer | ||
Gordon Naylor, CFO | ||
David Lamont, CFO | ||
Laurie Reed, Senior Vice President - Human Resources | ||
Tadataka Yamada, Director | ||
Elizabeth Walker, Chief Human Resource Officer, Executive Vice President | ||
Christina Hickie, Sr Communications | ||
Marie McDonald, Independent Non-Executive Director | ||
John Shine, Independent Non-Executive Chairman of the Board | ||
Maurice Renshaw, Independent Non-Executive Director | ||
Robert Repella, Executive Vice President - Global Commercial Operations | ||
John Levy, Company Secretary |
CSL Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is CSL a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.13 | |||
Return On Asset | 0.0613 | |||
Profit Margin | 0.18 % | |||
Operating Margin | 0.25 % | |||
Current Valuation | 96.65 B | |||
Shares Outstanding | 964.43 M | |||
Shares Owned By Institutions | 0.07 % | |||
Price To Earning | 34.45 X | |||
Price To Book | 6.77 X | |||
Price To Sales | 9.04 X |
Pair Trading with CSL
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CSL position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CSL will appreciate offsetting losses from the drop in the long position's value.Moving together with CSL Pink Sheet
0.88 | CMXHF | CSL Limited | PairCorr |
0.65 | VRTX | Vertex Pharmaceuticals Financial Report 6th of May 2024 | PairCorr |
Moving against CSL Pink Sheet
0.59 | SGEN | Seagen Inc Earnings Call Tomorrow | PairCorr |
0.59 | WMT | Walmart Financial Report 16th of May 2024 | PairCorr |
0.5 | TSM | Taiwan Semiconductor Financial Report 18th of July 2024 | PairCorr |
0.49 | NVO | Novo Nordisk AS Financial Report 2nd of May 2024 | PairCorr |
0.48 | NONOF | Novo Nordisk AS | PairCorr |
The ability to find closely correlated positions to CSL could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CSL when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CSL - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CSL to buy it.
The correlation of CSL is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CSL moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CSL moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CSL can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CSL. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for CSL Pink Sheet analysis
When running CSL's price analysis, check to measure CSL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CSL is operating at the current time. Most of CSL's value examination focuses on studying past and present price action to predict the probability of CSL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CSL's price. Additionally, you may evaluate how the addition of CSL to your portfolios can decrease your overall portfolio volatility.
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities |